Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease

RMD Open

Volumn 2, Issue 1, 2016, Pages

  Shigemura, Tomonari ^a   Kaneko, Naoe ^b   Kobayashi, Norimoto ^a   Kobayashi, Keiko ^c   Takeuchi, Yusuke ^a   Nakano, Naoko ^b   Masumoto, Junya ^b   Agematsu, Kazunaga ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988417432     PISSN: None     EISSN: 20565933     Source Type: Journal    
DOI: 10.1136/rmdopen-2015-000223     Document Type: Article

References (28)

1. Sakane T, Takeno M, Suzuki N, et al. Behcet's disease. N Engl J Med 1999;341:1284-91.
2. Berman L, Trappler B, Jenkins T. Behcet's syndrome: a family study and the elucidation of a genetic role. Ann Rheum Dis 1979;38:118-21.
3. Molinari N, Koné Paut I, Manna R, et al. Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A 2003;122A:115-18.
4. Bird Stewart JA. Genetic analysis of families of patients with Behcet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis 1986;45:265-8.
5. Dixit VM, Green S, Sarma V, et al. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 1990;265:2973-8.
6. Opipari AW Jr, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 1990;265:14705-8.
7. Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004;430:694-9.
8. Hasegawa M, Fujimoto Y, Lucas PC, et al. A critical role of RICK/ RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 2008;27:373-83.
9. Catrysse L, Vereecke L, Beyaert R, et al. A20 in inflammation and autoimmunity. Trends Immunol 2014;35:22-31.
10. Ma A, Malynn BA. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol 2012;12:774-85.
11. Shimane K, Kochi Y, Horita T, et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum 2010;62:574-9.
12. Li H, Liu Q, Hou S, et al. TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population. Hum Genet 2013;132:293-300.
13. Ortiz-Fernandez L, Garcia-Lozano JR, Montes-Cano MA, et al. Lack of association of TNFAIP3 and JAK1 with Behçet's disease in the European population. Clin Exp Rheumatol 2015;33(Suppl 94):S36-9.
14. Novak U, Rinaldi A, Kwee I, et al. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 2009;113:4918-21.
15. Duong BH, Onizawa M, Oses-Prieto JA, et al. A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. Immunity 2015;42:55-67.
16. Hammer GE, Turer EE, Taylor KE, et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 2011;12:1184-93.
17. Matmati M, Jacques P, Maelfait J, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 2011;43:908-12.
18. Vande Walle L, Van Opdenbosch N, Jacques P, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 2014;512:69-73.
19. Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet 2016;48:67-73.
20. [No authors listed]. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
21. Troppan K, Hofer S, Wenzl K, et al. Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma. PLoS ONE 2015;10:e0123922.
22. Sugiyama R, Agematsu K, Migita K, et al. Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations. Mol Biol Rep 2014;41:545-53.
23. Janssen CE, Rose CD, De Hertogh G, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol 2012;129:1076-84.
24. Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-kappa B and cell death responses in A20-deficient mice. Science 2000;289:2350-4.
25. Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995;270:286-90.
26. Aróstegui JI, Arnal C, Merino R, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 2007;56:3805-13.
27. Masumoto J, Yamazaki T, Ohta K, et al. Interleukin-1β suppression in Blau syndrome: comment on the article by Martin et al. Arthritis Rheum 2009;60:2544-5.
28. Gul A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005;4:81-3.